Breast cancer
Results
Phase 3
This trial looked at chemotherapy and everolimus for breast cancer that was HER2 positive. It was for women:
whose breast cancer had grown into surrounding tissue (locally advanced) or had spread to elsewhere in the body
who had not yet had any treatment for advanced breast cancer
Recruitment start: 10 September 2009
Recruitment end: 16 December 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Charles Swanton
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 15 November 2016
CRUK internal database number: 4540
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
